AKT1 and hepatocellular carcinoma: It has already been confirmed that overexpression of miR‐494,44 as well as increased insulin‐like growth factor 1 receptor (IGF1R) expression29 was responsible for triggering AKT signaling activation to mediate sorafenib primary resistance in HCC.